Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Expected Total Market Size Of The Pharmaceutical Manufacturing Industry By The Forecast Year 2029?
The pharmaceutical manufacturing market size has expanded considerably in recent years. It is projected to grow from $519.78 billion in 2024 to $572.33 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.1%. The growth observed in the past can be attributed to a rising global disease burden, increasing healthcare spending, growing demand for generic drugs, the expiration of patents for blockbuster drugs, and an expansion of pharmaceutical production capacity.
The pharmaceutical manufacturing market is projected to experience substantial expansion over the coming years. By 2029, its valuation is anticipated to reach $841.14 billion, demonstrating a compound annual growth rate (CAGR) of 10.1%. This projected growth stems from factors such as the rise of personalized medicine, an aging global population, increasing demand for biosimilar drugs, governmental backing for domestic production, and a higher incidence of chronic illnesses. Significant developments expected during this period involve progress in continuous production methods, the incorporation of artificial intelligence, the implementation of intelligent manufacturing solutions, new techniques in biologics manufacturing, and an emphasis on improving research and development effectiveness.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp
What Are The Key Drivers Of Growth In The Pharmaceutical Manufacturing Market?
The growing occurrence of chronic illnesses is anticipated to drive the expansion of the pharmaceutical manufacturing market in the future. These long-term health issues typically advance gradually and endure for at least a year, frequently necessitating continuous medical care or restricting daily routines. The higher incidence of chronic ailments stems from longer lifespans, inactive living, and poor eating habits, which in turn boosts the need for extended healthcare options and proactive health strategies. Pharmaceutical production plays a vital role in addressing chronic conditions by guaranteeing a consistent availability of crucial drugs, fostering advancements in drug creation, and fulfilling the escalating requirement for efficacious enduring treatment alternatives. As an illustration, in September 2024, data from the National Health Service, a UK-based government department, indicated that 11% of adults aged 35 and older suffer from advanced chronic kidney disease, a condition whose occurrence and seriousness intensify with age. Approximately 48% of individuals aged 75 and above are affected by some iteration of this illness, with 36% experiencing more advanced forms. Consequently, the expanding occurrence of chronic illnesses is stimulating growth within the pharmaceutical manufacturing market.
What Are The Segment Types Shaping The Pharmaceutical Manufacturing Market?
The pharmaceutical manufacturingmarket covered in this report is segmented –
1) By Molecule Type: Biologics And Biosimilars; Conventional Drugs
2) By Formulation: Tablets; Capsules; Injectable; Sprays; Suspensions; Powders; Other Formulations
3) By Route Of Administration: Oral; Topical; Parenteral; Inhalations; Other Route Of Administrations
4) By Therapy Area: Cardiovascular Diseases (CVDs); Pain; Diabetes; Cancer; Respiratory Diseases; Other Diseases
5) By Sales Channel: Retail; Non-retail
Subsegments:
1) By Biologics And Biosimilars: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell Therapies; Gene Therapies; Hormones; Blood And Plasma Products
2) By Conventional Drugs: Analgesics; Antipyretics; Antibiotics; Antivirals; Antifungals; Antihypertensives; Antidepressants; Antidiabetics
Which Market Trends Are Creating New Opportunities In The Pharmaceutical Manufacturing Industry?
Leading companies in the pharmaceutical manufacturing market are concentrating on developing advanced solutions, such as fully automated RLT manufacturing facilities. This focus aims to improve production efficiency, uphold high-quality standards, and address the increasing demand for targeted cancer therapies. An automated RLT manufacturing facility represents a state-of-the-art production site, employing sophisticated automation technologies to optimize and streamline the production of radioligand therapies, thereby ensuring manufacturing is consistent, efficient, and scalable. For example, in January 2024, Novartis AG, a Switzerland-based pharmaceutical corporation, obtained US Food and Drug Administration (FDA) approval for Pluvicto production at an advanced radioligand therapy (RLT) manufacturing facility located in Indianapolis. This development is expected to significantly enhance the production capacity for its radioligand therapy medicines, including Pluvicto and Lutathera. This expansion forms a key part of Novartis’ broader strategy to satisfy the expanding global demand for targeted cancer therapies and improve patient access across the world.
Who Are The Top Performing Companies In The Pharmaceutical Manufacturing Market In Recent Years?
Major companies operating in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report
How Is Pharmaceutical Manufacturing Market Demand Varying Across Different Regions?
North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Pharmaceutical Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24375&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Manufacturing Market 2025, By The Business Research Company
Companion Animal Pharmaceuticals Global Market Report 2025
Ethical Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ethical-pharmaceuticals-global-market-report
Biopharmaceuticals Contract Manufacturing Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model